CV Sciences, Inc.
CVSI
$0.0414
$0.00122.99%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -5.50% | -3.46% | -1.87% | -2.80% | 0.71% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -5.50% | -3.46% | -1.87% | -2.80% | 0.71% |
| Cost of Revenue | -6.20% | -4.21% | -4.28% | -8.49% | -6.17% |
| Gross Profit | -4.67% | -2.56% | 1.17% | 4.75% | 10.18% |
| SG&A Expenses | -9.36% | -13.93% | -8.06% | -5.71% | -9.96% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | 100.00% | 100.00% |
| Total Operating Expenses | -10.76% | -12.26% | 41.47% | 39.04% | 35.28% |
| Operating Income | 56.78% | 68.76% | -135.87% | -144.78% | -167.69% |
| Income Before Tax | 38.40% | 41.77% | -177.58% | -467.05% | -2,443.52% |
| Income Tax Expenses | -133.33% | -- | -33.33% | 93.48% | 93.48% |
| Earnings from Continuing Operations | 38.61% | 41.99% | -177.18% | -443.77% | -1,741.56% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 38.61% | 41.99% | -177.18% | -443.77% | -1,741.56% |
| EBIT | 56.78% | 68.76% | -135.87% | -144.78% | -167.69% |
| EBITDA | 71.18% | 81.23% | -125.78% | -134.82% | -153.17% |
| EPS Basic | 46.84% | 50.00% | -166.50% | -420.83% | -2,357.14% |
| Normalized Basic EPS | 38.03% | 63.55% | -138.41% | -151.16% | -194.67% |
| EPS Diluted | 47.17% | 50.24% | -166.83% | -422.92% | -2,371.43% |
| Normalized Diluted EPS | 38.03% | 63.55% | -138.41% | -151.16% | -194.67% |
| Average Basic Shares Outstanding | 13.69% | 15.40% | 14.01% | 10.44% | 7.33% |
| Average Diluted Shares Outstanding | 13.69% | 15.40% | 14.01% | 10.44% | 7.33% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |